Table 2.

Characteristics of patients with a severe course of COVID-19

Characteristics	Patient 1	Patient 2	Patient 3	Patient 4
Age range	40–50	50–60	50–60	70–80
Sex	Male	Female	Female	Female
Underlying disease	RA + Sjogren’s syndrome	Systemic lupus erythematosus + Sjogren’s syndrome	RA	RA
Treatment	RTX	RTX	RTX	RTX
Time interval between last RTX dose and occurrence of COVID-19 (months)	7	5	2	7
Risk factors for severe evolution of COVID-19
Tobacco	Former	Former	Active	No
Other comorbidities	None	None	Pulmonary rheumatoid nodule with lobectomy	None
Intensive care	Yes	Yes	Yes	Yes
Death	No	No	Yes	No

RA, rheumatoid arthritis; RTX, rituximab.